Neratinib (Nerlynx) 40 mg by Puma Biotechnology, Inc is used for intensive adjuvant therapy after treatment with HER2-positive breast cancer with trastuzumab (Herceptin).
$1,900.00
Neratinib (Nerlynx) 40 mg by Puma Biotechnology, Inc is used for intensive adjuvant therapy after treatment with HER2-positive breast cancer with trastuzumab (Herceptin).